Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy

Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment. Alongside their many advantages, they elicit immune-related adverse events, including myopathy, which potentially result in substantial morbidity if not recognized and treated promptly. Current knowledge of immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Shelly, Shahar, Triplett, James D, Pinto, Marcus V, Milone, Margherita, Diehn, Felix E, Zekeridou, Anastasia, Liewluck, Teerin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713997/
https://www.ncbi.nlm.nih.gov/pubmed/33305263
http://dx.doi.org/10.1093/braincomms/fcaa181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713997/
https://www.ncbi.nlm.nih.gov/pubmed/33305263
http://dx.doi.org/10.1093/braincomms/fcaa181

Ejemplares similares